Monalizumab Biosimilar - Anti-NKG2A Antibody - BSA and Azide free (A318877)

Monalizumab Biosimilar - Anti-NKG2A Antibody - BSA and Azide free

Recombinant humanized monoclonal antibody to NKG2A.

Flow Cytometry: 1:100

Human

Humanized

Monoclonal

IgG4

Unconjugated

Affinity chromatography.

Reconstitution dependent.

Reconstitute with distilled sterile water.

Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.

C lectin type II protein, CD159 antigen like family member A, CD159 antigen-like family member A, CD159a, CD159a antigen, Killer cell lectin like receptor subfamily C member 1, KLRC1, MGC13374, MGC59791, Natural killer cell lectin, Natural killer cell protein group 2-A1, Natural killer cell receptor NKG2A, Natural killer group protein 2, NK cell receptor A, NKG2, NKG2 1/B activating NK receptor, NKG2 A, NKG2 A/B activating NK receptor, NKG2 A/B type II integral membrane protein, NKG2 A/NKG2 B type II integral membrane protein, NKG2 B, NKG2-1/B activating NK receptor, NKG2-A/B-activating NK receptor, NKG2-A/NKG2-B type II integral membrane protein, NKG2A_HUMAN, NKG2B, rNKG2A